0 évaluation0% ont trouvé ce document utile (0 vote)
38 vues50 pages
The adrenal gland is a cap-like organ sitting at the upper pole of the kidney. Adrenal cortex is divided into three zones: zona glomerulosa, zona fasciculata, zona reticularis. Corticotropin secretion is under feedback regulation by the adrenal steroids.
The adrenal gland is a cap-like organ sitting at the upper pole of the kidney. Adrenal cortex is divided into three zones: zona glomerulosa, zona fasciculata, zona reticularis. Corticotropin secretion is under feedback regulation by the adrenal steroids.
The adrenal gland is a cap-like organ sitting at the upper pole of the kidney. Adrenal cortex is divided into three zones: zona glomerulosa, zona fasciculata, zona reticularis. Corticotropin secretion is under feedback regulation by the adrenal steroids.
(ADRENAL STEROIDS) The adrenal gland is a cap-like organ sitting at the upper pole of the kidney. Histologically, the gland consists of the inner adrenal medulla and the outer adrenal cortex (shell). In accord with this histological differentiation, there are two endocrine organs within the adrenal gland, one surrounding the other. The inner adrenal medulla secretes the catecholamines: epinephrine and norepinephrine. The outer adrenal cortex secretes corticosteroid hormones: glucocorticoids and mineralocorticoids. 2 The adrenal cortex is divided into three zones:
zona glomerulosa (outer), zona fasciculata (middle), and zona reticularis (inner).
Although these three zones are variable in their anatomical distinctness, they are definite in their biochemical distinctness. All three cortical zones secrete corticosterone: the zona glomerulosa biosynthesizes aldosterone; the zona fasciculate and zona reticularis biosynthesize cortisol (and sex hormones as well). 3 Like most endocrine glands, the adrenal cortex is regulated by hypothalamo-pituitary peptides. The hypothalamus secretes corticotropin releasing factor (CRF), which controls the release of adrenocorticotropin (ACTH), a peptide consisting of 39 amino acids. Corticotropin secretion is under feedback regulation by the adrenal steroids, as well as being under the control of higher CNS centers; stress or epinephrine can also increase corticosteroid production. Adrenocortical secretion is controlled primarily by ACTH from the anterior pituitary, but mineralocorticoid secretion is also subject to independent control by circulating factors, of which the most important is angiotensin II. 4 On the basis of biochemical effects, the two groups of corticosteroids can be readily distinguished:
1. Glucocorticoids, which act on carbohydrate, fat, and protein metabolism 2. Mineralocorticoids, which regulate electrolyte balance through Na + retention
Since these two classes of corticosteroids are both important in medicinal chemistry and drug design, 5 STEROID HORMONES: ADRENOCORTICOIDSGLUCOCORTICOIDS
Glucocorticoids have important metabolic effects on carbohydrates, proteins, and lipids; they stimulate phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, and glycogen synthase. Glucocorticoids promote gluconeogenesis by increasing the pyruvate carboxylase concentration, and thus increase the concentration of oxaloacetate in the mitochondrial pathway of pyruvatephosphoenolpyruvate synthesis.
6 Glucocorticoid Receptor
The glucocorticoid receptor protein belongs to a superfamily of nuclear receptor proteins that includes steroid, Vitamin D, thyroid, retinoic acid, and other receptors that interact with promoters that regulate the transcription of target genes. Although the glucocorticoid receptor differs from the estrogen or progesterone receptors, the basic principles of its action seem to be the same. The glucocorticoid receptor is 800 amino acids in length and has three functional domains: the C-terminal has the glucocorticoid binding region, the middle portion has the DNA binding region (containing nine cysteine residues folded into a two finger structure stabilized by Zn 2+ ions), and the N- terminal, which has the receptor-specific region. A gene for the classic glucocorticoid receptor has been identified. Binding to the glucocorticoid receptor is somewhatdependent on temperature, being optimal at 37C. 7 Glucocorticoids: StructureActivity Correlations
The structureactivity relationships of glucocorticoids are based on two natural hormones, cortisol (15.1) and corticosterone (15.2). The characteristic structural features of these hormones are the conjugated 3- ketone, the 11-OH group, and the l7 beta-ketol side chain. Molecular modifications have been aimed at deriving compounds with glucocorticoid (and anti-inflammatory) actions but lacking in mineralocorticoid effects and side effects. Substituents added to the cortisol molecule may alter bioactivity and receptor binding affinity independently of other functional groups present on the molecule. Cortisol (15.1) O OH H H H OH HO O Corticosteron (15.2) O H H H OH HO O 8 1. Halogenation. 9 lfa-Fluorocortisone is only about 10 times more active than its parent compound, but its mineralocorticoid activity is 300600 times greater. This is undesirable since it leads to edema; thus, the compound fludrocortisone (15.3) is used only topically, in ointments. 2. Additional double bonds. 1-compounds (where .1 indicates the position of a double bond) were introduced, like prednisone (15.4), a .1-11-ketone, and prednisolone, its 11-hydroxy analogue. Changing the geometry of the A ring increased the potency without augmenting mineralocorticoid activity. Fluorocortison (15.3) O OH H H F OH HO O Prednison (15.4) O OH H H H OH O O 9 The introduction of a methyl group in methylprednisolone (15.5) resulted in a slight increase in activity; however, the greatest improvements in activity came from the combination of a double bond, halogen, and methyl substituents. Triamcinolone (15.6), in the form of its acetomide (an acetone ketal), shows a 9-fluoro group in addition to .1 unsaturation, and a 16-OH. It is used in treating psoriasis and other dermatological problems. Methylprednison (15.5) O OH H H H OH HO O Triamcinolon (15.6) O OH H H F OH HO O OH 10 Dexamethasone (15.7), perhaps the most active and highly stable glucocorticoid, is the 16lfa-methyl analog of triamcinolone. It is interesting to note that progesterone binds well to the glucocorticoid receptor despite a missing 11-oxygen functional group, but it fails to elicit gene activation in glucocorticoid target cells, thus shedding light on the role of the 11-OH group. The optimum glucocorticoid structure shows a 1lfa, 2bet-half-chair conformation for ring A, with ring D as a 13-envelope (C-13 is bent up) or a half-chair. Halogenation is most effective in positions 6, 7, 9, and 12. The compounds bind on their face by hydrophobic binding forces. Dexamethason (15.7) O OH H H H OH HO O 11 5.12.3 Glucocorticoids: Pharmacological Activity
The most important clinical application of glucocorticoids and their semisynthetic analogs is their anti-inflammatory activity, discovered in 1949 by Hench and co- workers. The profound anti-inflammatory effects of glucocorticoids arise from the combined effects of these steroids on both the cellular and molecular mediators of inflammation; these effects are separate from the metabolic effects described above and further indication of the widespread diversity of macromolecules to which steroids can bind. Glucocorticoids suppress inflammation at the cellular level by downregulating the concentration, distribution, and function of leukocytes (white blood cells) that profoundly influence inflammation and response to infection within the body (In this way, steroids help to mediate the overlap between the endocrine systems [chapter 5] and the immune systems [chapter 6]). Glucocorticoids also suppress inflammation at the molecule level by suppressing inflammatory cytokines, chemokines, and other molecular mediators of inflammation. 12 Glucocorticoids: Inflammation versus Infection
The use of anti-inflammatory steroids also demands an appreciation of the differences between the processes of infection and inflammation. An infection is a pathological process whereby an exogenous agent (fungus, bacterium, virus, prion) invades the body, either locally or systemically, causing some form of injurious dysfunction. Inflammation, on the other hand, is the bodys physiological endogenous response to an injury, be it caused by an infective agent or some other process (trauma, chemical). Although inflammation is a normal physiological response, it may become pathological under certain circumstances; for example, inflammation of the bronchi in the lungs due to inhalation of a toxic chemical may cause so much swelling in the bronchial lining that the flow of air into the lung is blocked, resulting in a pathological state. 13 Infections are usually accompanied by inflammation. The reddened area around a skin abscess reflects the bodys inflammatory response to the infection. If one puts topical steroids on such an infection, the redness disappears, reflecting suppression of the inflammation and giving the erroneous impression that the infection has been successfully treated; in truth, the infection is now spreading much more aggressively since the bodys inflammatory defense system has been suppressed. Nevertheless, sometimes it is necessary to cautiously use anti-inflammatory steroids in the presence of an infection. For example, pneumonia may be associated with a dangerous inflammation of the airways, causing decreased air entry into the lungs. Under such circumstances, the combined use of an anti- inflammatory steroid with the appropriate antibiotic is justified. 14 STEROID HORMONES: ADRENOCORTICOIDSMINERALOCORTICOIDS
Mineralocorticoids such as the natural hormone aldosterone (5.66) regulate electrolyte concentration by stimulating Na + retention in kidney cells. 11-Desoxycorticosterone (5.67) and fludrocortisone (5.62) are much less active, but are used for maintaining electrolyte balance in adrenal insufficiency. Aldosterone synthesis is probably regulated by ACTH and angiotensin, a peptide hormone. This hormone has its own receptors in kidney cells. Hyperaldosteronism can play a role in high blood pressure. Aldosterone (15.8) O H H H OH HO O O 11-Deoxycorticosteron (15.9) O H H H OH O 15 Spironolacton (15.10) O H H H O O S O Aldosterone antagonists such as spironolactone (15.10) are therefore useful as hypotensive diuretic agents, because the increase in Na + excretion that they promote is always paralleled by an increased urine volume. 16 Structurally, aldosterone differs from glucocorticoids in having an 18- aldehyde group and lacking the 17-OH. The aldehyde participates in a tautomeric equilibrium, forming a cyclic hemiacetal ring. Spironolactone, a synthetic compound and antiandrogen, has a lactone ring attached to C-17 through one common carbon (a spiro compound) and the 7-thiolester group. The structure of the mineralocorticoid receptor has been deduced through cloning of its cDNA. It shows considerable structural and functional similarity to the glucocorticoid receptor. 17 The most important pharmacological action of glucorticoids and their semisynthetic analogues is their
a. antiinflammatory b. and antirheumatic activity, discovered in 1949 by Hench and co-workers.
18 Relative glucocorticoid and mineralocorticoid activity of some corticoid derivatives Relative glucocorticoid potency Relative meneralocorticoid activity Cortisol 1 1 Fluorocortison 10 300 Prednison 3 0,8 Methylprednisolone 5 0 Triamcinolone 6 0 Dexamethason 30 0 11-deoxycorticosterone 0 30 Aldosteron 0,2 600 19 Although the mode of action of glucocorticoids is unknown, there are certain indications that:
a. they interfere with prostaglandin and collagenase synthesis, b. and the circulatory distribution of leukocytes in inflamed tissue, c. as well as inhibiting edema by decreasing capillary permeablity.
20 These steroids are also effective:
a. in some allergic diseases, such as bronchial asthma b. and in urticaria c. and other types of dermatitis. 21 LIPIDS AS DRUGS AND DRUG DESIGN TARGETS
In 1934, von Euler in Sweden discovered a group of polyunsaturated fatty acids that had a powerful effect on smooth muscle and blood pressure. They were isolated from seminal fluid and the prostate, and were named prostaglandins. Their structure was elucidated by the Samuelsson group in Stockholm, who, in 1975, also discovered even more potent fatty acid metabolites, the thromboxanes and prostacyclin. The effect of these compounds on blood platelet aggregation and the contraction of blood vessels connected them to the etiology of stroke and cardiovascular disease. Additionally, it was discovered that both steroidal and nonsteroidal anti-inflammatory agents act through the prostaglandin system, adding further impetus to the research in this area. Consequently, the field of bioactive lipids became a center of intense interest. 22 As the research area expanded, the leukotrienes were discovered next. The leukotrienesare potent lipid mediators associated with asthma and allergic reactions. In contrast to prostaglandins, leukotrienes are made predominantly in inflammatory cells, like leukocytes, macrophages, and mast cells. Prostaglandins, thromboxane, and the leukotrienes are lipids that are collectively called eicosanoids, since they are all derived from the C20 fatty acid, arachidonic acid [eicosa (Gr.) = twenty]. Over the past twenty years, the eicosanoids have emerged as important molecules around which to target drug design and development. 23 Prostaglandins A, PGB, PGC are inactive degradation products. O PGA O PGB O PGC OH PGD O O PGE HO 24 Pharmacological effects of prostaglandins and thromboxane Blood vessels Bronchi Protaglandin E2 Dilatation Dilatation Oxytocic Prostagcyclin ( PGI2) Dilatation Agregation ihb Prostaglandin E2 Contriction Contriction Oxytocic Thromboxane (TXA2) Contriction Agregation Compouns Platelet Uterus 25 Prostaglandins, prostacyclin, and thromboxane are considered local hormones or autocoid, synthesized in many different organs and acting locally. They are not stored like neurotransmitters or conventional hormones, but are continuously synthesized and released immediately into the circulation, where they are usually deactivated after only one passage through the lungs. The synthesis depends on the availability of the starting material, arachidonic acid, and is modulated by c AMP. 26 3. The oxytocic activity of prostaglandin is used clinically. Prostaglandin E2 can indude labor at term in pregnant women, while PGF2 and its ester is probably due to a direct effect on uterine muscle.
4. Other effects of the prostaglandins include bronchodilation by the PGE series and constriction by PGF2, as well as anti-ulcer and antisecretory effects of some synthetic analogues in the stomach. 27 The following effects of prostaglandins 1. Vasodilation and constriction: PGE2 and especially PGI2 (prostagcyclin) are powerful, short-acting vasodilators, probably involved in blood-pressure regulation. Prostaglandin F2 and TXA2. on the other hand, are potent vasoconstrictors. 2. Blood-phlatelet aggregation is an all-important mechanism in normal blood-clot (thrombus ) formation, and therefore also highly significant in the pathophysiology of cardiovascular disease, stroke, coronary occlusion, and other circulatory catastrophes. 28 E. Antiinflammatory Agents and Minor Analgesic Antiinflammatory agents are believed to act by distrupting the arachidonic-acid cascade. These drugs are widely used for the treatment of minor pain and also for the management of edema and the tissue damage resulting from arthritis.
The adrenal steroids (corticosteroids) probably act by blocking phospholipase A 2 . the enzyme that liberates arachidonic acid from phospholipids. These steroid also inhibit collagenase, an enzyme responsible for damage to the cartilaginous tissue in joints affected by arthritic diseases.
29 8.5.1 Prostaglandins and Thromboxanes
8.5.1.1 Prostaglandins: Structure and Biosynthesis The biosynthesis of prostaglandins and thromboxanes starts from arachidonic acid. Arachidonic acid, obtained from its phospholipid form by the action of phospholipase A, is cyclized to prostaglandin endoperoxide (15.11) in the form of PGG (a side-chain peroxide), from which PGH2 (a side-chain hydroxyl) is obtained. Interleukin-1, a cytokine produced by leukocytes and possessing multiple immunological roles, mediates inflammation by increasing phospholipase activity and thus prostaglandin synthesis. The first reaction in prostaglandin biosynthesis is catalyzed by PG cyclooxygenase in the presence of O2 and heme. The second reaction requires tryptophan, probably as a source of electrons. 30 CO 2 H O O Prostaglandine Endoperoxide (15.11) OH 31 Structure of prostaglandin and thromboxanes CO 2 H O HO OH PGE 1 CO 2 H O HO OH PGE 2 1 2 4 7 10 13 20 32 CO 2 H Arachidonic acid Phospholipase Phospholipid C Phospholipid-esterified arachidonic acid O CH CH 2 OCO(CH 2 ) n CH 3 CH 2 OPOR O O 33 CO 2 H Arachidonic acid Phospholipase Phospholipid Corticosteroids 34 The non steroidal antiinflammatory agents block the cyclooxygenase that converts arachidonic acid to PGG2 and PGH2. Since the cyclic endoperoxidides are the prcursors of all prostaglandins, the synthesis of the latter is interupted. CO 2 H Arachidonic acid(AA) CO 2 H O O Non steroidal antiinflammatory agents AA cyclooxygenase 2 O 2 Prostaglandin endoperoxida O[O]H 35 Leukotrienes,- which have been called slow- reacting substance (SRS) -are compounds intimately involved in anaphylactic reaction, allergic reactions, and asthma. Like the prostaglandins, thye are lipids, formed from arachidonic acid by lipoxygenase and glutathione. Their structure and biosynthesis were also elucidated by the Samuelsson group (Samuelsson, 1980), and are shown in Fiq. 36 CO 2 H CO 2 H OOH H C 5 H 11 O CO 2 H Arachidonic acid(AA) Lipoxygenase 5-HPETE Leukotriene A (LTA) 37 Anti-Prostaglandins as Anti-Inflammatory Agents and Minor Analgesics
Anti-inflammatory agents are believed to act by disrupting the arachidonic acid cascade. These drugs are widely used for the treatment of minor pain and arthritis. Some of them are antipyretics (drugs that reduce fever) in addition to having analgesic and antiinflammatory actions. Some of these agents are widely available in over-the-counter (OTC) preparations. Collectively, these are referred to as nonsteroidal anti-inflammatory drugs (NSAIDs). They may be classified as follows: 38 1) NSAIDs: Non-selective cyclo-oxygenase inhibitors
a. Arylanthranilic acids (mefenamic acid, meclofenamate) b. Arylbutyric acids (nabumetone) c. Arylpropionic acids (ibuprofen, ketoprofen, fenoprofen, naproxen, ketorolac) d. Indene derivatives (sulindac) e. Indole derivatives (indomethacin) f. Naphthylacetic acid derivatives (nabumetone) g. Oxicams (piroxicam, meloxicam, tenoxicam) h. Phenylacetic acid derivatives (diclofenac) i. Phenylalkanoic acid derivatives (flurbiprofen) j. Pyrazolone derivatives (phenylbutazone, azapropazone) k. Pyrrolealkanoic acid derivatives (tolmetin) l. Salicylate derivatives (aspirin, diflunisal)
2) NSAID: Selective COX-2 inhibitors a. Coxibs (celecoxib, rofecoxib)
39 The nonsteroidal anti-inflammatory agents block the cyclooxygenase enzyme that catalyzes the conversion of arachidonic acid to the prostaglandins PGG2 and PGH2. Since these two cyclic endoperoxides are the precursors of all other prostaglandins, the implications of cyclooxygenase inhibition are significant. Prostaglandin E1 is known to be a potent pyrogen (fever-causing agent), and PGE2 causes pain, edema, erythema (reddening of the skin), and fever. The prostaglandin endoperoxides (PGG2 and PGH2) can also produce pain, and inhibition of their synthesis can thus account for the action of the nonsteroidal anti- inflammatory agents. 40 Most of the nonsteroidal anti-inflammatory drugs (NSAIDs) are carboxylic acids. Aspirin (8.69) (acetylsalicylic acid, ASA) has been used since the turn of the last century to reduce pain and fever, but the parent compound, salicylic acid, has been known and used since antiquity, owing to its common occurrence as a glycoside in willow bark. Acetylation merely decreases its irritating effect. Among the numerous other salicylates known and used, flufenisal (8.70) has a longer duration of activity and fewer side effects than aspirin. 41 Mefenamic acid (8.71) and flufenamic acid (8.72) are derivatives of anthranilic acid, while ibuprofen (8.73) and naproxen (8.74) are derivatives of phenylacetic and naphthylacetic acids, respectively. 42 Among indole derivatives, indomethacin (8.75) is very widely used despite side effects. Its indene analog sulindac (8.76) is a pro-drug, the active form being its SH derivative. Piroxicam (8.77) is a long-lasting anti-rheumatoid agent but can have serious gastrointestinal side effects. The once widely used phenylbutazone (8.78) derivatives have too many side effects and have fallen into disrepute. 43 Among the nonselective cyclooxygenase (COX) inhibitors, there is no clear-cut statistical evidence for the superiority of one or another of these useful drugs. Individual patients may do better with some than with others, and there are differences in side effects, primarily gastric bleeding and renal toxicity, which can be especially serious with the prolonged administration of high doses necessary in chronic diseases such as rheumatoid arthritis. Some of these compounds are powerful enough to be effective against the major pain caused by malignancies. 44 Most of the nonsteroidal antiinflammatory drugs are carbocylic acids, Aspirin (acetylsalicylic acid, ASA), has been used since the turn of the century to reduce pain and fever, but the parent compound, salicylic acid, has been known and used since antiquity, owing to its common occurrence as a glycoside in willo bark. Acetylation merely decreases its irritating effect. Among the numerous other salicylates known and used, flufenisal has a longaer duration of activity and fewer side effects than aspirin. 45 In theory the selective COX-2 inhibitors may offer some advantages. There are at least two forms of the COX enzyme: COX-1 and COX-2. COX-1 is located in most tissues, including stomach and kidneys. COX-2, on the other hand, is undetectable in most tissues under physiological conditions. COX-2 is induced at sites of inflammation, secondary to the effects of cytokines. Accordingly, specific COX-2 inhibitors, such as celecoxib (8.79) and rofecoxib (8.80), are less likely to cause stomach ulceration and gastrointestinal bleeding. Nevertheless, they still have the capacity to cause fluid retention and renal damage. More significantly, in 2004 it was recognized that COX- 2 inhibitors may pose an increased cardiovascular risk. For example, rofecoxib was suddenly withdrawn from the market when it was noted that there was an increased relative risk for confirmed cardiovascular events, including heart attack and stroke, beginning after 18 months of treatment, compared to placebo. 46 47 Anti-Leukotrienes as Anti-Inflammatory Agents for Asthma
Like the other eicosanoids, the leukotrienes are also involved in inflammatory diseases. Accordingly, leukotriene pathway inhibitors are emerging as important agents. Two fundamental approaches to the design of leukotriene pathway inhibitors have been pursued:
Zileuton (8.81) is an inhibitor of 5-lipoxygenase; montelukast (8.82) and zafirlukast (8.83) are inhibitors of the leukotriene LTD4 receptor. All of these agents have demonstrated efficacy in the treatment of asthma, a common chronic inflammatory disease of the airways. 48 49 OC COOH Aspirin CH 3 O OC COOH Flufenisal CH 3 O F Mefenemic acid and flufenamic acid are derivatives of anthranilic acid, while ibuprofen and naproxen are derivatives of phenyl acetic acid and naphthylacetic acid, respectively. NH COOH Mefenemic Acid CH 3 CH 3 NH COOH Flumefenemic Acid CF 3 50 H C COOH Ibuprofen CH 3 CH 3 CH 3 H 2 C CH COOH Naproxen CH 3 CH H 3 CO COOH Indomethazcin CH 3 H 2 C N H 3 CO C Cl O